Bristlecone Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,239
| Closed | -$417K | – | 371 |
|
|
2024
Q3 | $417K | Buy |
6,239
+47
| +0.8% | +$3.14K | 0.03% | 200 |
|
|
2024
Q2 | $735K | Buy |
6,192
+67
| +1% | +$7.96K | 0.06% | 154 |
|
|
2024
Q1 | $653K | Buy |
6,125
+126
| +2% | +$13.4K | 0.06% | 165 |
|
|
2023
Q4 | $597K | Buy |
5,999
+153
| +3% | +$15.2K | 0.06% | 165 |
|
|
2023
Q3 | $604K | Sell |
5,846
-200
| -3% | -$20.7K | 0.07% | 156 |
|
|
2023
Q2 | $735K | Buy |
6,046
+62
| +1% | +$7.53K | 0.07% | 150 |
|
|
2023
Q1 | $919K | Buy |
5,984
+254
| +4% | +$39K | 0.1% | 133 |
|
|
2022
Q4 | $1.03M | Buy |
5,730
+179
| +3% | +$32.2K | 0.13% | 126 |
|
|
2022
Q3 | $656K | Sell |
5,551
-79
| -1% | -$9.34K | 0.09% | 143 |
|
|
2022
Q2 | $804K | Buy |
5,630
+2,774
| +97% | +$396K | 0.1% | 134 |
|
|
2022
Q1 | $492K | Sell |
2,856
-2,486
| -47% | -$428K | 0.06% | 159 |
|
|
2021
Q4 | $1.36M | Buy |
+5,342
| New | +$1.36M | 0.16% | 111 |
|